Cambrex Corp. (CBM) Misses Q4 EPS by 2c, Offers Weak FY12 Sales Guidance
Tweet
Share
E-mailGet Alerts CBM Hot Sheet
Price: $59.99 --0%
Financial Fact:
Income/(loss) from discontinued operations, net of tax: -0.14
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Income/(loss) from discontinued operations, net of tax: -0.14
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Cambrex Corp. (NYSE: CBM) reported Q4 EPS of $0.10, $0.02 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $67.1 million versus the consensus estimate of $64.85 million.
Cambrex Corp. sees FY2012 EBITDA of $47-$53 million. Cambrex Corp. sees FY2012 revenue of growth of 2-6%, versus the consensus of 5%.
For earnings history and earnings-related data on Cambrex Corp. (CBM) click here.
Cambrex Corp. sees FY2012 EBITDA of $47-$53 million. Cambrex Corp. sees FY2012 revenue of growth of 2-6%, versus the consensus of 5%.
For earnings history and earnings-related data on Cambrex Corp. (CBM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
